Chair and Professor, Department of Urology, Mayo Clinic
Urology
Dr. Bradley C. Leibovich, MD
|
|
Give Review
Bradley Leibovich is an expert in the field of Urology. He attended Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He has 13 awards "Fellow (FACS)", "Regional Top Doctor", "Teacher of the Year Hall of Fame", "Teacher of the Year", "Excellence in Teaching Recognition", "Pfizer Scholars in Urology Award", "Best Clinical Presentation Award", "James H. DeWeerd Travel Award", "Kelalis Resident Essy Award", "C. R. Bard Urological Award", "Daggett Trust Prize", "Alpha Omega Alpha Honor Medical Society" and "Dean's commendation for scholastic excellence". Bradley C. Leibovich, MD is a published physician. He has 99 publications published. The most current publication "Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy." Bradley Leibovich is registered with Medicare.
Publications
- Observations on transatlantic renal cell Cancer surgery outcomes.
- Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
- Paraneoplastic syndromes are associated with adverse prognosis among patients with Renal cell carcinoma undergoing nephrectomy.
- A novel prognostic model for patients with sarcomatoid Renal cell carcinoma.
- Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
- Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma.
- The High-Dose Aldesleukin "Select" Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Oncologic outcomes following surgical resection of Renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter...
- Mayo Adhesive Probability Score: An Accurate Image-based Scoring System to Predict Adherent Perinephric Fat in Partial Nephrectomy.
- Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Ne...
- Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partia...
- Diabetes Mellitus is Independently Associated with an Increased Risk of Mortality Among Clear Cell Renal Cell Carcinoma Patients.
- Robot Assisted Retroperitoneal Lymph Node Dissection: Technique and Initial Case Series of 18 Patients.
- The impact of histology on survival for patients with metastatic Renal cell carcinoma undergoing cytoreductive nephrectomy.
- Multimodality therapy including surgical resection and intraoperative electron radiotherapy for recurrent or advanced primary carcinoma of the urinary Bladder or ureter.
- Higher Expression of Topoisomerase II Alpha Is an Independent Marker of Increased Risk of Cancer-specific Death in Patients with Clear Cell Renal Cell Carcinoma.
- Perioperative Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus Extending Above the Hepatic Veins: A Contemporary Multicen...
- The impact of perioperative Blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
- The impact of histology on clinicopathologic outcomes for patients with Renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.
- Re: Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, et al. Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Result...
- Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons.
- Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell Renal cell carcinoma (ccRCC) after long-term follow-up.
- A novel grading system for clear cell Renal cell carcinoma incorporating tumor necrosis.
- Iatrogenic splenectomy during nephrectomy for Renal tumors.
- Percutaneous Ablation of Renal Masses Measuring 3.0 cm and Smaller: Comparative Local Control and Complications After Radiofrequency Ablation and Cryoablation.
- The Effect of Benign Lower Urinary Tract Symptoms on Subsequent Prostate Cancer Testing and Diagnosis.
- Association of Microvascular and Capillary-Lymphatic Invasion with Outcome for Patients with Renal Cell Carcinoma.
- Overall Survival and Development of Stage IV Chronic Kidney Disease in Patients Undergoing Partial and Radical Nephrectomy for Benign Renal Tumors.
- Chromophobe Renal cell carcinoma: the impact of tumor grade on outcome.
- Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis.
- Clinical and pathological features associated with prognosis in patients with papillary Renal cell carcinoma.
- Contemporary trends in nephrectomy for Renal cell carcinoma in the United States: results from a population based cohort.
- Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary Kidney.
- Complications following 573 Percutaneous Renal Radiofrequency and Cryoablation Procedures.
- A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes.
- Outcomes and Clinicopathologic Variables Associated With Late Recurrence After Nephrectomy for Localized Renal Cell Carcinoma.
- Survival after complete surgical resection of multiple metastases from Renal cell carcinoma.
- International Consultation on Urologic Diseases and the European Association of Urology International Consultation on Locally Advanced Renal Cell Carcinoma.
- Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort.
- Dynamic prediction of metastases after radical prostatectomy for prostate Cancer.
- Metastatic potential of a Renal mass according to original tumour size at presentation.
- Long-Term Outcomes After Maximal Surgical Resection and Intraoperative Electron Radiotherapy for Locoregionally Recurrent or Locoregionally Advanced Primary Renal Cell...
- Routine Adrenalectomy in Patients with Locally Advanced Renal Cell Cancer Does Not Offer Oncologic Benefit and Places a Significant Portion of Patients at Risk for an ...
- Treatment of patients with small Renal masses: a survey of the American Urological Association.
- Percutaneous image-guided adRenal cryoablation: procedural considerations and technical success.
- Metachronous Renal tumours after surgical management of oncocytoma.
- AdRenal hematoma after nephrectomy.
- Percutaneous cryoablation of anterior Renal masses: technique, efficacy, and safety.
- Renal nephrometry score is associated with Urine leak after partial nephrectomy.
- Percutaneous Renal cryoablation: local control at mean 26 months of followup.
- Unclassified Renal cell carcinoma: impact on survival following nephrectomy.
- Percutaneous cryoablation of Renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
- Surgical treatment of Renal cell carcinoma in the immunocompromised transplant patient.
- Histological subtype is an independent predictor of outcome for patients with Renal cell carcinoma.
- Gadolinium enhanced magnetic resonance urography for upper Urinary tract malignancy.
- Outcome of stage T2 or greater renal cell Cancer treated with partial nephrectomy.
- Concomitant surgery for Renal neoplasm with pulmonary tumor embolism.
- Partial versus radical nephrectomy for 4 to 7 cm Renal cortical tumors.
- T-cell co-regulatory molecule expression in Renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
- Multicenter evaluation of an investigational prostate Cancer methylation assay.
- Locally recurrent prostate Cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
- Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell Renal cell carcinoma.
- Use of high fidelity operating room simulation to assess and teach communication, teamwork and laparoscopic skills: initial experience.
- Lymph node dissection in the management of Renal cell carcinoma.
- Outcomes following partial nephrectomy by tumor size.
- Long-term outcomes of radical Prostatectomy with multimodal adjuvant therapy in men with a preoperative serum Prostate-specific antigen level > or =50 ng/mL.
- Hormone receptor expression in Renal angiomyolipoma: clinicopathologic correlation.
- Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell Renal cell carcinoma.
- Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell Renal ...
- Serum-soluble B7x is Elevated in renal cell carcinoma patients and is associated with advanced stage.
- Predicting disease progression after nephrectomy for localized Renal cell carcinoma: the utility of prognostic models and molecular biomarkers.
- T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
- Surgical resection of isolated retroperitoneal lymph node recurrence of Renal cell carcinoma following nephrectomy.
- Re: Location of extraRenal tumor extension does not impact survival of patients with pT3a Renal cell carcinoma. V. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A....
- Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass.
- What is the clinical significance of ipsilateral Renal lesions during nephron-sparing surgery?
- Urology resident training with an unexpected patient death scenario: experiential learning with high fidelity simulation.
- Preoperative nomogram predicting 12-year probability of metastatic renal Cancer.
- Percutaneous Renal cryoablation: experience treating 115 tumors.
- Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.
- Small (<2-cm) upper-Tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography.
- Radical retropubic Prostatectomy in immunosuppressed transplant recipients.
- External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell Renal cell carcinoma.
- Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a Renal remnant.
- Questionable relevance of gamma delta T lymphocytes in Renal cell carcinoma.
- Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell Renal cell carcinoma.
- Radical nephrectomy for pT1a Renal masses may be associated with decreased overall survival compared with partial nephrectomy.
- Differences in organ system of distant metastasis by Renal cell carcinoma subtype.
- The role of partial nephrectomy for the management of sporadic Renal angiomyolipoma.
- Surgical resection provides excellent outcomes for patients with cystic clear cell Renal cell carcinoma.
- Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell Renal cell carcinoma.
- Potential underdetection of pT(3a) Renal-cell carcinoma with laparoscopic morcellation.
- Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell Renal cell carcinoma and not surrogates for each other.
- Is the GPSM scoring algorithm for patients with prostate Cancer valid in the contemporary era?
- Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy.
- Patients with pT1 Renal cell carcinoma who die from disease after nephrectomy may have unrecognized Renal sinus fat invasion.
- Percutaneous cryoablation of large Renal masses: technical feasibility and short-term outcome.
- Percutaneous cryoablation of 40 solid Renal tumors with US guidance and CT monitoring: initial experience.
Schools
Med College
Mayo Grad School MedMayo Fndn
Procedures Preformed
- AdRenalectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Awards
- Fellow (FACS)
- Regional Top Doctor
- Teacher of the Year Hall of Fame
- Teacher of the Year
- Excellence in Teaching Recognition
- Pfizer Scholars in Urology Award
- Best Clinical Presentation Award
- James H. DeWeerd Travel Award
- Kelalis Resident Essy Award
- C. R. Bard Urological Award
- Daggett Trust Prize
- Alpha Omega Alpha Honor Medical Society
- Dean's commendation for scholastic excellence
Education
-
UCLA Medical Center -
Mayo School of Graduate Medical Education -
Indiana University School of Medicine -
Albany Medical College -
Cornell University
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1699755405 | |
| NPPES Provider LastName | LEIBOVICH | |
| NPPES Provider FirstName | BRADLEY | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Urology | |
| Total Claim Count | 60.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699755405 |
| Last Name Of The Provider | LEIBOVICH |
| First Name Of The Provider | BRADLEY |
| View All |
Similar Doctors
|
|
Dr. Stephen A. Boorjian, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Eugene D. Kwon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew T. Gettman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Griffin T. Morrisson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haidong Dong, MD
This Doctor is OpenDoctor Recommended.
|